A test to detect tumour DNA circulating in the blood can predict lung cancer outcomes, finds new research from scientists at UCL, the Francis Crick Institute, UCLH and Personalis. Circulating tumour DNA (ctDNA) describes fragments of DNA that have been released into the blood by tumours. ctDNA is known to be important for disease prognosis, but can be difficult to measure precisely. In a CRUK-funded study published in Nature Medicine , UCL and Crick scientists worked with biotechnology company

Tag-uri: DNA